Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents
Type of Study: Animal Study
Year of Pub: 2022
Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
Type of Study: Laboratory Study
Year of Pub: 2021
Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
Type of Study: Laboratory Study
Year of Pub: 2021
Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats
Type of Study: Animal Study
Year of Pub: 2021
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice
Type of Study: Laboratory Study
Year of Pub: 2021
Development and Optimization of Supercritical Fluid Extraction Setup Leading to Quantification of 11 Cannabinoids Derived from Medicinal Cannabis
Type of Study: Laboratory Study
Year of Pub: 2021
Fast liquid chromatography-tandem mass spectrometry method for the simultaneous determination of phytocannabinoids in oily based preparations
Type of Study: Laboratory Study
Year of Pub: 2021
Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms
Type of Study: Laboratory Study
Year of Pub: 2021
Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
Type of Study: Meta-analysis
Year of Pub: 2021
Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry
Type of Study: Laboratory Study
Year of Pub: 2021
An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
Type of Study: Laboratory Study
Year of Pub: 2021
Screening and confirmation methods for the qualitative identification of nine phytocannabinoids in urine by LC-MS/MS
Type of Study: Laboratory Study
Year of Pub: 2021
The Cannabinoids Tetrahydrocannabinol, Cannabinol, Cannabidiol, Tetrahydrocannabivarin, and 11-nor-9-carboxy-∆9-THC in Hair
Type of Study: Laboratory Study
Year of Pub: 2021
Quantitation of Δ8-THC, Δ9-THC, Cannabidiol, and Ten Other Cannabinoids and Metabolites in Oral Fluid by HPLC-MS/MS
Type of Study: Laboratory Study
Year of Pub: 2021
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Type of Study: Meta-analysis
Year of Pub: 2021
Specific Compositions of Cannabis sativa Compounds Have Cytotoxic Activity and Inhibit Motility and Colony Formation of Human Glioblastoma Cells In Vitro
Type of Study: Laboratory Study
Year of Pub: 2021
Beneficial effects of the phytocannabinoid Δ 9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
Type of Study: Animal Study
Year of Pub: 2020
Antioxidant and antimicrobial activity of two standardized extracts from a new Chinese accession of non-psychotropic Cannabis sativa L
Type of Study: Laboratory Study
Year of Pub: 2020
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Type of Study: Meta-analysis
Year of Pub: 2020
High fat-fed GPR55 null mice display impaired glucose tolerance without concomitant changes in energy balance or insulin sensitivity but are less responsive to the effects of the cannabinoids rimonabant or Δ(9)-tetrahydrocannabivarin on weight gain
Type of Study: Animal Study
Year of Pub: 2020
Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath
Type of Study: Laboratory Study
Year of Pub: 2020
It Is Our Turn to Get Cannabis High: Put Cannabinoids in Food and Health Baskets
Type of Study: Meta-analysis
Year of Pub: 2020
Cannabinoids and Cannabinoid Receptors: The Story so Far
Type of Study: Meta-analysis
Year of Pub: 2020
Synthesis of the Major Mammalian Metabolites of THCV
Type of Study: Meta-analysis
Year of Pub: 2020
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Type of Study: Meta-analysis
Year of Pub: 2019
Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence
Type of Study: Animal Study
Year of Pub: 2019
Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes
Type of Study: Laboratory Study
Year of Pub: 2019
Effects of non‐euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx mice
Type of Study: Laboratory Study
Year of Pub: 2018
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study.
Type of Study: Double Blind Human Trial
Year of Pub: 2016
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Type of Study: Double Blind Human Trial
Year of Pub: 2016
The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers
Type of Study: Double Blind Human Trial
Year of Pub: 2016
Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers
Type of Study: Double Blind Human Trial
Year of Pub: 2015
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
Type of Study: Meta-analysis
Year of Pub: 2015
The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects
Type of Study: Animal Study
Year of Pub: 2015
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.
Type of Study: Animal Study
Year of Pub: 2013
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats
Type of Study: Animal Study
Year of Pub: 2013
Δ8-Tetrahydrocannabivarin Prevents Hepatic Ischaemia/Reperfusion Injury by Decreasing Oxidative Stress and Inflammatory Responses Through Cannabinoid CB2 Receptors
Type of Study: Animal Study
Year of Pub: 2012
Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
Type of Study: Laboratory Study
Year of Pub: 2012
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
Type of Study: Animal Study
Year of Pub: 2011
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Type of Study: Meta-analysis
Year of Pub: 2009
The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum
Type of Study: Laboratory Study
Year of Pub: 2008
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo
Type of Study: Animal Study
Year of Pub: 2007